These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11085077)

  • 1. [PSA--monitoring the prostate. Diagnostic series: Early detection of prostatic carcinoma].
    Janssen K
    MMW Fortschr Med; 2000 Oct; 142(41):45. PubMed ID: 11085077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
    Kuruma H; Egawa S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen: current status.
    Lukes M; Urban M; Záleský M; Zachoval R; Herácek J; Zdárský E
    Folia Biol (Praha); 2001; 47(2):41-9. PubMed ID: 11321246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of PSA in diagnosis of prostate carcinoma].
    Weissbach L
    Internist (Berl); 1999 Feb; 40(2):219. PubMed ID: 10097984
    [No Abstract]   [Full Text] [Related]  

  • 5. Early detection of prostate cancer: is PSA a reliable option?
    Okihara K; Babaian RJ
    Tex Med; 2001 Feb; 97(2):59-62. PubMed ID: 11233061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostate cancer].
    Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

  • 8. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early detection of prostatic cancer].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):193-4. PubMed ID: 1381124
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of PSA-density: analysis in PSA gray zone cases].
    Ishizuka O; Iwata K; Igawa Y; Nishizawa O
    Hinyokika Kiyo; 2001 Sep; 47(9):611-3. PubMed ID: 11692595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of the new criteria based on the serum quantification of prostate-specific antigen in the early diagnosis of prostatic cancer].
    Morote Robles J
    Actas Urol Esp; 1996 Jan; 20(1):1-12. PubMed ID: 8720993
    [No Abstract]   [Full Text] [Related]  

  • 12. AUA issues a policy report on PSA monitoring. The American Urological Association.
    Scott Morey S
    Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostatic specific antigen: role and significance in urologic practice].
    Manolović D; Pejcić T; Milović N
    Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Model of screening for prostatic cancer among patients with prostate specific antigen concentration of 4-10 ng/ml in blood].
    Karazanashvili GG; Managadze LG
    Urologiia; 2000; (6):37-41. PubMed ID: 11186321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
    Perrin P
    Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].
    Medvedev VL
    Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
    Partin AW; Brawer MK; Bartsch G; Horninger W; Taneja SS; Lepor H; Babaian R; Childs SJ; Stamey T; Fritsche HA; Sokoll L; Chan DW; Thiel RP; Cheli CD
    J Urol; 2003 Nov; 170(5):1787-91. PubMed ID: 14532777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations].
    Kawai M; Okajima K; Kobayashi K; Moriyama M
    Hinyokika Kiyo; 2006 Feb; 52(2):113-7. PubMed ID: 16541764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA: prostate-specific antigen, persisting scientific ambiguities.
    Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.